TEVA
Teva Pharmaceutical Industries Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$36.36
−0.71%Forward multiples
Based on analyst estimates
- P/E forward
- 12.97x
- P/E 2026E
- 18.40x
- P/E 2027E
- 11.97x
- P/E 2028E
- 10.68x
- P/S forward
- 2.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- 57.71x
- PEG TTM
- 0.17x
- Price / book
- 5.46x
- Price / sales
- 2.45x
- Price / cash flow
- 22.32x
Enterprise value
- Enterprise value
- $55.6B
- EV / sales
- 3.21x
- EV / EBITDA
- 21.43x
- EV / EBIT
- 28.03x
- Market cap
- $42.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026